Brief: Redwood Pharma To Be Granted Patent In China Regarding IntelliGel
Feb 10 (Reuters) - Redwood Pharma AB REDWPH.TE :
* PATENT TO BE GRANTED IN CHINA REGARDING INTELLIGEL
* CHINA NATIONAL INTELLECTUAL PROPERTY ADMINISTRATION
(CNIPA) HAS
COMMUNICATED ITS INTENTION TO GRANT A NEW PATENT IN CHINA IN
PORTFOLIO LICENSED TO REDWOOD PHARMA FROM BRODA INTERNATIONAL
LLC
Source text for Eikon: ID:nWkr8C5Rgj
Further company coverage: REDWPH.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Redwood Pharma AB
See all newsBrief: Redwood Pharma Says Files For Bankruptcy
Brief: Redwood Pharma Provides New Update Regarding Divestment Of Company Assets
Brief: Redwood Pharma Updates On Process For Divesting Assets
Brief: Redwood Pharma To Propose Liquidation At EGM
Brief: Redwood Pharma: Minimum Level In Rights Issue Not Reached